Utah Approves Nolla Health's AI to Write First-Time Prescriptions: A U.S. First, $4.99/mo

What Happened

The clearance comes from two agencies under the Utah Department of Commerce: the Office of Artificial Intelligence Policy (OAIP) and the Division of Professional Licensing. They signed an agreement with Nolla's operating entity, Magic Health — on September 22 the pilot appeared on the state's public list of authorized AI pilots. The core of the agreement is a non-enforcement promise: the state agrees not to pursue unlicensed-practice or telehealth violations for AI-issued first-time topical acne prescriptions. But the fine print is explicit: this is a grant of regulatory mitigation only, not an endorsement by the State of Utah. The pilot runs 12 months, renewable for two more years.

Here's the flow: patients download the Nolla Derm app, verify identity, complete informed consent, fill a 10-to-15-minute intake questionnaire, then take a five-angle face scan. The AI analyzes the skin, scores oiliness and acne severity (from clear to severe), combines it with medical history, and picks a medication from a physician-preapproved list. Nolla stresses the difference from telehealth platforms: those use AI to collect information and hand off to a clinician for the actual prescription; its system independently issues initial prescriptions within tightly defined, physician-approved treatment protocols. Bloomberg Law, STAT, Medical Economics, Becker's Hospital Review and MobiHealthNews all covered the launch the same day.

Key Facts

1. Why acne: a 61-day wait vs $4.99/month: Nolla's numbers: only about 10% of Utahns with acne ever see a dermatologist, and the average appointment wait is 61 days. The app subscription is $4.99/month; compounded medications run about $50/month (meds billed separately). Per Becker's, the Nolla app has been downloaded more than 175,000 times across 44 states — but this pilot is open only to Utah adults 18 and older.
2. Scope: 8 topical treatments: The AI can only choose from 8 pre-approved topical treatments. Oral medications and isotretinoin (Accutane) are explicitly excluded; severe acne and other unsuitable cases get screened out and routed to a licensed physician. If the AI can't confidently pick a treatment, the patient goes to a human doctor — this is written into the agreement.
3. Physician oversight phases down in three stages: every Rx → daily → weekly: First 100 patients: two Utah-licensed physicians approve every AI-generated prescription before it goes out. Through patient 500: the AI prescribes on its own, physicians review its decisions daily after the fact. After that: physicians review a weekly sample of at least 10%. Nolla says clinicians agreed with the AI's recommendations in more than 96% of real-world cases, the rest needing only minor dose or strength tweaks — note: that's the company's own claim, not independently verified.
4. Utah's earlier AI prescribing pilots were refills only: Utah's OAIP is the country's first AI regulatory sandbox. It had already cleared AI prescribing pilots for Doctronic (refills for nearly 200 chronic-condition medications) and Legion Health (psychiatric-drug refills) — both refills of drugs a doctor had already prescribed. This is the first time AI may write a prescription from scratch. The earlier Doctronic pilot drew criticism from physicians over the lack of real consultation.
5. Founder's claim vs the approved scope: Founder Luis Wenus (ex-Worldcoin) called it the "first ever end-to-end AI doctor" on X. The approval covers one state, one condition, 8 topical drugs and a 12-month regulatory waiver; the company raised $4.5M last year (including General Catalyst). Nolla plans to extend AI prescribing to more conditions, and each step needs new regulatory approval.

Context

Writing a prescription carries diagnostic responsibility, and in every US state that responsibility rests with a licensed physician. Telehealth platforms have used an "AI intake + doctor approves" model. Utah's OAIP sandbox lets the state waive regulations for specific AI products, using a non-enforcement promise in place of unlicensed-practice enforcement; the agreement also makes malpractice coverage and a board-appointed physician Nolla's responsibility, with no endorsement or liability from the state.